S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
S&P 500   3,925.43
DOW   31,961.86
QQQ   324.13
Log in
LON:EVG

Evgen Pharma Share Forecast, Price & News

GBX 9.29
+0.19 (+2.09 %)
(As of 02/25/2021 10:12 AM ET)
Add
Compare
Today's Range
8.90
Now: GBX 9.29
9.29
50-Day Range
9.15
MA: GBX 10.13
11.24
52-Week Range
2.50
Now: GBX 9.29
17
Volume222,185 shs
Average Volume1.24 million shs
Market Capitalization£12.76 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Evgen Pharma plc, a clinical stage drug development company, engages in developing sulforaphane based medicines for the treatment of multiple diseases. Its core technology is Sulforadex, which include synthetic and stabilized analogues of the naturally occurring compound sulforaphane. The company's lead product is SFX-01, a synthetic version of sulforaphane stabilised that is in Phase II clinical trials for the treatment of metastatic breast cancer and subarachnoid haemorrhage, as well as in preclinical stage for multiple sclerosis and clinical stage to treat prostate cancer, autism, non-alcoholic steatohepatitis, and chronic kidney diseases. Evgen Pharma plc was founded in 2007 and is headquartered in Wilmslow, the United Kingdom.
Evgen Pharma logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-151-7053532
Employees9
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£194,000.00
Cash FlowGBX 1.68 per share
Book ValueGBX 1.90 per share

Profitability

Miscellaneous

Market Cap£12.76 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.60 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
GBX 9.29
+0.19 (+2.09 %)
(As of 02/25/2021 10:12 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EVG News and Ratings via Email

Sign-up to receive the latest news and ratings for EVG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Evgen Pharma (LON:EVG) Frequently Asked Questions

What stocks does MarketBeat like better than Evgen Pharma?

Wall Street analysts have given Evgen Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Evgen Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Evgen Pharma's earnings last quarter?

Evgen Pharma plc (LON:EVG) released its quarterly earnings data on Monday, June, 15th. The company reported ($2.10) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($2.10).
View Evgen Pharma's earnings history
.

How has Evgen Pharma's stock been impacted by Coronavirus (COVID-19)?

Evgen Pharma's stock was trading at GBX 4.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, EVG stock has increased by 100.0% and is now trading at GBX 8.90.
View which stocks have been most impacted by COVID-19
.

Who are Evgen Pharma's key executives?

Evgen Pharma's management team includes the following people:
  • Mr. Richard Anthony Moulson, CFO & Exec. Director (Age 59, Pay $85.4k)
  • Dr. Huw Jones, Chief Exec. Officer (Age 61)
  • Ms. Liz Jenkins, Regulatory Consultant
  • Dr. Thomas Morris, Consultant & Medical Advisor of Oncology
  • Prof. Albena Dinkova-Kostova, Independent Scientific Advisor
  • Prof. Giovanni Mann, Independent Scientific Advisor

Who are some of Evgen Pharma's key competitors?

What other stocks do shareholders of Evgen Pharma own?

What is Evgen Pharma's stock symbol?

Evgen Pharma trades on the London Stock Exchange (LON) under the ticker symbol "EVG."

How do I buy shares of Evgen Pharma?

Shares of EVG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Evgen Pharma's stock price today?

One share of EVG stock can currently be purchased for approximately GBX 8.90.

How much money does Evgen Pharma make?

Evgen Pharma has a market capitalization of £12.23 million and generates £194,000.00 in revenue each year.

How many employees does Evgen Pharma have?

Evgen Pharma employs 9 workers across the globe.

What is Evgen Pharma's official website?

The official website for Evgen Pharma is evgen.com.

Where are Evgen Pharma's headquarters?

Evgen Pharma is headquartered at The Colony 146 Brownlow Hill, Altrincham Road, WILMSLOW, SK9 4LY, United Kingdom.

How can I contact Evgen Pharma?

Evgen Pharma's mailing address is The Colony 146 Brownlow Hill, Altrincham Road, WILMSLOW, SK9 4LY, United Kingdom. The company can be reached via phone at +44-151-7053532.


This page was last updated on 2/25/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.